Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia (Transcript)

[at Seeking Alpha] – Mathai Mammen Good afternoon everyone and thank you for joining us. I’m quite excited to tell you about the recent results from the Phase II study with TD-9855, a novel norepinephrine serotonin and reuptake … more

View todays social media effects on THRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Theravance is hiring next, click here to view